Once-daily oral verapamil may help preserve stimulated C-peptide secretion for children and adolescents with type 1 diabetes, according to a study published in JAMA. In findings from a randomized ...

C-peptide test can help in the correct diagnosis and treatment of diabetes. This simple and cheap test can differentiate between Type-1 and Type-2 diabetes, as well as other genetic forms of diabetes.

Foteinopoulou E et al. Impact of routine clinic measurement of serum C‐peptide in people with a clinician‐diagnosis of type 1 diabetes. Diabetic Medicine . November 1, 2020.

A C-peptide measurement, however, should not be used alone to diagnose type 1 diabetes. The official diagnostic criteria require both high blood sugar levels and the presence of the autoimmune ...

Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with ...

Professor Mark Strachan, from Western General Hospital, Edinburgh, said: "We have now measured C-peptide in over 750 people with a clinician-diagnosis of Type 1 diabetes, attending our clinic at ...

Understanding the limitations of type 1 diabetes diagnosis criteria and the importance of accurate classification to improve health outcomes, an integrated clinical team at University Hospital of ...

We studied 334 patients, 10 to 20 years of age, with type 1 diabetes, fasting C-peptide levels of more than 0.3 ng per milliliter (0.1 nmol per liter), and detectable serum GAD65 autoantibodies.

The proportion of patients with detectable nonfasting C-peptide decreased with longer duration of type 1 diabetes, but remained consistently and significantly higher among those diagnosed as ...

“We know that preserving beta cell function and preserving C-peptide secretion in people with type 1 diabetes for as long as possible translates into benefits,” Drucker, a senior scientist at ...

Most patients with new-onset type 1 diabetes have substantial intact beta-cell reserve. 1 Thus, we analyzed the efficacy of semaglutide, an agonist of glucagon-like peptide 1 (GLP-1), in patients ...